Skip to main content
Home News DJO® Acquires MedShape, Inc.

DJO® Acquires MedShape, Inc.

Businesswire, April 26, 2021

Acquisition expands foot and ankle business and adds innovative shape memory technologies

DJO, a subsidiary of Colfax Corporation (NYSE: CFX) and a leading global provider of medical technologies to get and keep people moving, today announced that it has completed the acquisition of MedShape, Inc., a privately held orthopedic medical device company founded in 2005. MedShape® provides innovative surgical solutions for foot and ankle surgeons using its patented superelastic nickel titanium (NiTiNOL) shape memory alloy and shape memory polymer technologies.

The acquired business’ portfolio includes innovative devices for fracture fixation, joint fusion and soft tissue injury repair that utilize biomaterial technologies designed to improve patient outcomes. The superelastic properties of NiTiNOL are leveraged to create devices that actively participate and respond to changes at the surgical site, such as bone resorption, maintaining compression and bony apposition throughout healing. MedShape’s DynaNail® TTC Fusion System, launched in 2011, has over 30 clinical publications and podium presentations showing decreased failure rates and improved fusion times utilizing NiTiNOL technology compared to static solutions.

“Based on our long-term success and deep relationships in both our Prevention & Recovery and Recon segments, we made a strategic decision to meaningfully expand into the fast-growing Foot and Ankle market. We believe our acquisitions of STAR®, Trilliant Surgical®, and now MedShape have created a strong position in the space and will create a rapid growth platform,” said Brady Shirley, CEO of DJO. “MedShape’s patented technology and growing suite of foot & ankle innovations complement our existing portfolio and strengthen our key strategic imperative of superior clinical outcomes.”

The Foot and Ankle market is expected to grow and reach $1.58B by 2025.Among the factors driving the market are a rapidly growing elderly population, increasing prevalence of diabetes and a number of sports-related injuries.4 The MedShape® product line opens a new market entry for a suite of surgical solutions that actively participate in the bone healing process and creates new options for self-adapting foot and ankle implants.

“As the industry leader in developing shape memory technologies and successfully applying that science to foot and ankle products, we have unbounded future potential,” said Ken Gall, Ph.D., Professor at Duke University and Co-founder of MedShape. “We are excited to continue developing and integrating this breakthrough science to expand into other areas of orthopedics leveraging DJO’s market leadership, patient outcome focus and commitment to product innovation.” Dr. Gall will take on a new role at DJO and become the Chief Scientific Officer for the growing Reconstructive segment.

For more information, visit


Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us